Ultragenyx Pharmaceutical Inc.
RARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001515673
In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 5 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.
Superinvestors holding RARE, Q2 2026
No superinvestor reported holding RARE in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of RARE each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2025
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office
Q3 2024
1 superinvestor holding at quarter end
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−42.4%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−9.0%)